Page 8 - Anjali Singh

Hospitals vs insurers: Policyholders bear the brunt of rising medical costs

The simmering conflict came to a head last month when Niva Bupa suspended cashless services at Max Hospitals on August 16, citing unresolved reimbursement issues

Novartis' Vymada patent revoked, generics set to slash prices by 70%

Novartis lost its Vymada patent in India, enabling generic drugmakers to launch versions that could slash prices by up to 70 per cent and improve access for cardiac patients

FADA dealer Satisfaction Study 2025: JSW MG, Enfield emerge segment leaders

The fifth edition of DSS was conducted in partnership with Singapore-based consultancy PremonAsia

Apollo Hospitals to acquire IFC's 30.5% in health and lifestyle arm

Apollo Hospitals to acquire IFC's 30.58% stake in AHLL for Rs 1,254 crore, taking ownership to 99.42%, and invest Rs 573 crore in a next-gen proton therapy centre in Gurugram

AHPI warns Star Health it may halt cashless service over 'unfair practices'

In a strongly worded communication sent to the insurer, AHPI flagged long-standing grievances, including the refusal to revise hospital tariffs in line with rising healthcare costs

GST cut relief: Two-wheeler prices may decline by as much as ₹24,500

The GST Council recently cut tax rates on sub-350cc two-wheelers and three-wheelers from 28 per cent to 18 per cent, effective September 22, 2025

JBM Auto's Ecolife gets $100 mn IFC funding to expand e-bus operations

JBM Ecolife Mobility secured $100 million from IFC to deploy 1,455 electric buses in Maharashtra, Assam, and Gujarat, marking IFC's first capital investment in Asia's e-bus sector

Weak IP regime clouds pharma growth despite GST cuts, says BMI report

BMI warned India's weak IP protections deter global drugmakers, limiting access to innovative therapies, even as GST cuts on 33 lifesaving drugs lower costs and boost affordability

New drug offers hope for Indians with drug-resistant hypertension

Baxdrostat lowered systolic blood pressure in trials and could benefit Indian patients with resistant hypertension by reducing side effects of older drugs

Hospitals may raise IT innovation spend by 20-25% amid AI boost: Report

CII-EY survey finds AI, automation, and data-led tools driving hospital tech investments despite challenges in integration and workforce readiness

Sun Pharma's Halol plant gets OAI classification from US FDA inspection

US FDA has classified Sun Pharma's Halol facility in Gujarat as OAI, keeping it under import alert, signalling possible enforcement action unless corrective steps are taken

Glenmark gains 3% on $700 mn upfront payment from AbbVie licensing deal

Glenmark shares rose 3% after confirming receipt of $700 million from AbbVie under a global licensing deal for ISB 2001, with milestone payments of up to $1.2 billion

TVS invests ₹100 cr in NTorq 150 launch, eyes festive scooter demand

TVS Motor has invested Rs 100 crore in its NTorq 150 Hyper Sport Scooter, aiming to capture festive-season demand and consolidate its position in the premium scooter market

Anti-obesity diabetes drugs receive WHO's essential medicine tag

India is preparing for large-scale generic launches

Citroen to double India market share in 3 months with Basalt X SUV

Citroen eyes stronger India play with Basalt X SUV, aiming to double market share in three months while exports from Thiruvallur are projected to cross 10,000 units in FY26

Pharma market grows 8.7% in August; cardiac and anti-diabetic segments lead

The Indian Pharma Market grew 8.7% in August 2025, with the cardiac, anti-diabetic, and anti-neoplastic segments driving growth. Sun Pharma maintained its leadership position

Patients to benefit from GST rate cut, but firms likely to face pressure

GST rationalisation lowers costs for medical consumables and high-end therapies, benefiting patients. However, pharma companies, particularly in biologics, may face margin pressure due to ITC loss

New GST rates revive auto companies' hope for a festive sales spurt

Small petrol and diesel cars now attract only 18 per cent GST compared to 29-31 per cent earlier

From cancer drugs to glucometers, patients to save more after GST cuts

GST Council removed tax on 33 life-saving drugs and slashed GST on all medicines and medical devices to 5%, easing treatment costs and improving healthcare access

GST cut makes cars, bikes, tyres cheaper, Diwali comes for Auto Inc

GST Council cut rates on small cars, bikes, SUVs and tyres, slashing levies to 18% and rationalising slabs, a move hailed as transformative for the auto industry